EA200601795A1 - Синтез эфиров бороновой кислоты и кислотных соединений - Google Patents

Синтез эфиров бороновой кислоты и кислотных соединений

Info

Publication number
EA200601795A1
EA200601795A1 EA200601795A EA200601795A EA200601795A1 EA 200601795 A1 EA200601795 A1 EA 200601795A1 EA 200601795 A EA200601795 A EA 200601795A EA 200601795 A EA200601795 A EA 200601795A EA 200601795 A1 EA200601795 A1 EA 200601795A1
Authority
EA
Eurasian Patent Office
Prior art keywords
synthesis
boronic acid
acid
ethers
compounds
Prior art date
Application number
EA200601795A
Other languages
English (en)
Other versions
EA012927B1 (ru
Inventor
И. Фразер Пикерсгилл
Джон Бишоп
Кристоф Кёльнер
Жан-Марк Гомез
Ахим Гайзер
Роберт Хетт
Винс Аммоскато
Стефен Мунк
Янг Ло
Фанг-Тинг Чуй
Витхалананд Р. Кулкарни
Original Assignee
Миллениум Фармасьютикалз, Инк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601795(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Миллениум Фармасьютикалз, Инк filed Critical Миллениум Фармасьютикалз, Инк
Publication of EA200601795A1 publication Critical patent/EA200601795A1/ru
Publication of EA012927B1 publication Critical patent/EA012927B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Изобретение относится к синтезу эфиров бороновой кислоты и кислотных соединений. Более конкретно, изобретение касается усовершенствованных способов синтеза для крупномасштабного производства эфиров бороновой кислоты и кислотных соединений, включая ингибитор протеазомы на основе пептидной бороновой кислоты - бортезомиб.
EA200601795A 2004-03-30 2005-03-24 Синтез эфиров бороновой кислоты и кислотных соединений EA012927B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55753504P 2004-03-30 2004-03-30
PCT/US2005/009774 WO2005097809A2 (en) 2004-03-30 2005-03-24 Synthesis of boronic ester and acid compounds

Publications (2)

Publication Number Publication Date
EA200601795A1 true EA200601795A1 (ru) 2007-04-27
EA012927B1 EA012927B1 (ru) 2010-02-26

Family

ID=34968044

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601795A EA012927B1 (ru) 2004-03-30 2005-03-24 Синтез эфиров бороновой кислоты и кислотных соединений

Country Status (41)

Country Link
US (14) US7714159B2 (ru)
EP (5) EP2377868A1 (ru)
JP (4) JP4558039B2 (ru)
KR (1) KR100939598B1 (ru)
CN (5) CN108329337B (ru)
AR (3) AR049374A1 (ru)
AT (1) ATE521612T1 (ru)
AU (1) AU2005230930B2 (ru)
BR (1) BRPI0509587A (ru)
CA (4) CA2859119A1 (ru)
CL (2) CL2010000350A1 (ru)
CR (1) CR8653A (ru)
CY (3) CY1112053T1 (ru)
DK (4) DK3385267T3 (ru)
DO (1) DOP2011000293A (ru)
EA (1) EA012927B1 (ru)
EC (1) ECSP066960A (ru)
ES (3) ES2899606T3 (ru)
FI (1) FI4008721T3 (ru)
HK (4) HK1100004A1 (ru)
HR (4) HRP20212002T1 (ru)
HU (1) HUE056859T2 (ru)
IL (3) IL178250A (ru)
LT (2) LT3385267T (ru)
ME (1) ME01975B (ru)
MX (1) MX367324B (ru)
MY (1) MY145427A (ru)
NL (3) NL1028639C2 (ru)
NO (4) NO338905B1 (ru)
NZ (3) NZ598172A (ru)
PE (3) PE20110075A1 (ru)
PL (4) PL1756121T3 (ru)
PT (4) PT4008721T (ru)
RS (4) RS62738B1 (ru)
SG (5) SG182999A1 (ru)
SI (3) SI3385267T1 (ru)
TW (1) TWI386212B (ru)
UA (1) UA90108C2 (ru)
UY (3) UY28830A1 (ru)
WO (1) WO2005097809A2 (ru)
ZA (1) ZA200608689B (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030685B1 (ru) * 2008-06-17 2018-09-28 Милленниум Фармасьютикалз, Инк. Способ получения соединения боронатного эфира
EA034601B1 (ru) * 2007-08-06 2020-02-25 Милленниум Фармасьютикалз, Инк. Способ получения бороновых кислот

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
CA2859119A1 (en) 2004-03-30 2005-10-20 Millenium Pharmaceuticals, Inc. Synthesis of boronic ester and acid compounds
WO2008075376A1 (en) * 2006-12-18 2008-06-26 Natco Pharma Limited Polymorphic forms of bortezomib and process for their preparation
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
AU2016253697A1 (en) * 2007-08-06 2016-11-24 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
CA2695082C (en) * 2007-08-06 2015-07-28 Millennium Pharmaceuticals, Inc. Peptide boronic acid and boronic ester compounds as proteasome inhibitors
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
US20110118274A1 (en) * 2007-08-23 2011-05-19 Cornell Research Foundation, Inc. Proteasome inhibitors and their use in treating pathogen infection and cancer
KR20100051828A (ko) * 2007-09-12 2010-05-18 닥터 레디스 레보러터리즈 리미티드 보르테조밉 및 그의 제조방법
US7838673B2 (en) 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
AU2013204896A1 (en) * 2008-09-29 2013-05-16 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclobutylethylboronic acid
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
CN101899062B (zh) * 2009-05-26 2015-04-15 上海威智医药科技有限公司 α-手性硼酸及硼酸酯的合成工艺
EP2270019A1 (en) 2009-06-19 2011-01-05 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters
EP2280016A1 (en) 2009-07-27 2011-02-02 LEK Pharmaceuticals d.d. New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
JP2012530115A (ja) 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路
WO2011087822A1 (en) 2009-12-22 2011-07-21 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
WO2011090940A1 (en) 2010-01-19 2011-07-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
CA2789400A1 (en) 2010-02-09 2011-08-18 Ranbaxy Laboratories Limited Process for the preparation of bortezomib
CN101781326B (zh) * 2010-02-11 2013-08-21 福建南方制药股份有限公司 一种制备手性氨基硼酸的中间体及其制备方法
WO2011107912A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Polymorphic forms of bortezomib
KR101530942B1 (ko) * 2010-03-18 2015-06-23 이노파르마, 인코포레이티드 안정한 보르테조밉 포뮬레이션
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
MX2012011298A (es) 2010-03-31 2012-11-06 Millennium Pharm Inc Derivados del acido 1-amino-2-ciclopropiletilboronico.
CN101812026B (zh) * 2010-04-12 2013-08-28 亚邦医药股份有限公司 一种硼替佐米的合成方法
JP5881254B2 (ja) 2010-05-18 2016-03-09 セルリアン・ファーマ・インコーポレイテッド 自己免疫疾患およびその他の疾患の治療のための組成物および方法
EP2627636B1 (en) 2010-10-14 2015-09-02 Synthon BV Process for making bortezomib and the intermediates for the process
TW201309303A (zh) 2011-03-03 2013-03-01 Cephalon Inc 用於治療狼瘡的蛋白酶體抑制劑
CN102206188B (zh) * 2011-04-08 2013-02-27 苏州二叶制药有限公司 N-(吡嗪-2-基羰基)-l-苯丙氨酸的制备方法
US8497374B2 (en) 2011-05-12 2013-07-30 Scinopharm Taiwan, Ltd. Process for preparing and purifying bortezomib
CN102268029B (zh) * 2011-05-19 2013-10-09 苏州二叶制药有限公司 化合物（1s,2s,3r,5s）-蒎烷二醇-l-苯丙氨酸-l-亮氨酸硼酸酯的制备
JP5944986B2 (ja) 2011-06-22 2016-07-05 セファロン、インク． プロテアソーム阻害剤、ならびにそれらの調製、精製、および使用のためのプロセス
CN102351890B (zh) * 2011-09-30 2014-07-02 重庆泰濠制药有限公司 一种硼替佐米的合成方法
CN102492021B (zh) * 2011-12-13 2013-10-23 重庆泰濠制药有限公司 硼替佐米的制备工艺
MX352652B (es) 2011-12-22 2017-12-04 Ares Trading Sa Inhibidores de inmunoproteasoma selectivos de derivados del acido alfa-amino boronico.
CN103374026A (zh) * 2012-04-27 2013-10-30 重庆医药工业研究院有限责任公司 一种硼替佐米中间体的制备方法
CN103450331B (zh) * 2012-06-05 2016-05-25 山东新时代药业有限公司 一种硼替佐米的精制方法
MX2015003175A (es) * 2012-09-11 2015-07-14 Cipla Ltd Proceso para preparacion de bortezomib.
WO2014072985A1 (en) 2012-11-06 2014-05-15 Natco Pharma Limited Novel boronic acid derivatives as anti cancer agents
EP2919786A4 (en) 2012-11-16 2016-06-01 Shilpa Medicare Ltd PROCESS FOR PREPARING CRYSTALLINE BORTEZOMIB
US9422314B2 (en) 2012-12-07 2016-08-23 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
CN103897026A (zh) * 2012-12-29 2014-07-02 朱继东 硼替佐米关键中间体的晶型，制备方法及其运用
CN103897027A (zh) * 2012-12-29 2014-07-02 曹亚英 关键中间体晶型，制备方法及其在硼替佐米合成中的运用
ES2730013T3 (es) 2013-01-10 2019-11-07 Venatorx Pharmaceuticals Inc Inhibidores de betalactamasa
WO2014170628A1 (en) 2013-04-16 2014-10-23 Cipla Limited Process for the preparation of bortezomib mannitol ester
CN104211758B (zh) * 2013-05-29 2020-06-12 深圳翰宇药业股份有限公司 一种硼替佐米的制备方法
CN103497233B (zh) * 2013-09-30 2015-04-08 哈药集团技术中心 一种硼替佐米的制备方法
CN103554219A (zh) * 2013-10-01 2014-02-05 昆明贵研药业有限公司 一种制备硼替佐米的方法
KR101691353B1 (ko) * 2013-12-09 2016-12-30 주식회사 경보제약 보르테조밉의 제조방법 및 그의 신규 중간체
WO2015117136A1 (en) 2014-02-03 2015-08-06 Ohio State Innovation Foundation Boronic acid esters and pharmaceutical formulations thereof
SG11201609259VA (en) 2014-05-20 2016-12-29 Millennium Pharm Inc Boron-containing proteasome inhibitors for use after primary cancer therapy
RU2686740C2 (ru) 2014-06-11 2019-04-30 Венаторкс Фармасьютикалс, Инк. Ингибиторы бета-лактамазы
JP6420629B2 (ja) * 2014-10-30 2018-11-07 ボーグワーナー インコーポレーテッド チェーンガイドおよびチェーンテンショナアーム
DE102015204151A1 (de) * 2015-03-09 2016-09-15 Adidas Ag Ball, insbesondere Fußball, und Verfahren zur Herstellung eines Balls
JP6223508B2 (ja) * 2016-06-27 2017-11-01 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． プロテアソーム阻害剤
US10889600B2 (en) 2016-08-04 2021-01-12 VenatoRx Pharmaceuticals, Inc. Boron-containing compounds
CN110312727A (zh) * 2017-02-17 2019-10-08 费森尤斯卡比肿瘤学有限公司 一种改进的制备硼酸酯的方法
EP3592362A4 (en) 2017-03-06 2020-09-02 Venatorx Pharmaceuticals, Inc. SOLID FORMS AND COMBINATION COMPOSITIONS WITH A BETA LACTAMASE INHIBITOR AND USES THEREOF
US11267826B2 (en) 2017-05-26 2022-03-08 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2018218190A1 (en) 2017-05-26 2018-11-29 VenatoRx Pharmaceuticals, Inc. Penicillin-binding protein inhibitors
WO2019020099A1 (zh) 2017-07-28 2019-01-31 成都地奥九泓制药厂 一种硼酸酯化合物、其合成方法及其用途
CA3074247A1 (en) * 2017-09-02 2019-03-07 Sun Pharmaceutical Industries Limited Process for the preparation of ixazomib citrate
CN111187336B (zh) * 2018-11-14 2022-05-20 正大天晴药业集团股份有限公司 硼替佐米的精制方法
US11964993B2 (en) 2021-07-03 2024-04-23 Shilpa Pharma Lifesciences Limited Crystalline bortezomib process

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525309A (en) 1983-03-15 1985-06-25 Washington State University Research Foundation, Inc. Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents
US4537773A (en) 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US4701545A (en) 1986-02-12 1987-10-20 Washington State University Research Foundation, Inc. Preparation of α,α-dihaloalkyl boronic esters
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
DK3078667T3 (en) * 2001-01-25 2019-01-07 The United States Of America Represented By The Sec Dep Of Health And Human Services Formulation of boric acid compounds
WO2003033507A1 (fr) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derives d'acide benzylmalonique et inhibiteurs de proteasomes les contenant
WO2003033506A1 (fr) * 2001-10-12 2003-04-24 Kyorin Pharmaceutical Co., Ltd. Derive d'acide d'aminoborane et medicament inhibiteur de proteasomes le contenant
CA2859119A1 (en) * 2004-03-30 2005-10-20 Millenium Pharmaceuticals, Inc. Synthesis of boronic ester and acid compounds
WO2009004350A1 (en) * 2007-07-03 2009-01-08 Pliva Hrvatska D.O.O. Methods for preparing bortezomib and intermediates used in its manufacture
US7838673B2 (en) * 2007-10-16 2010-11-23 Millennium Pharmaceuticals, Inc. Proteasome inhibitors
JP2012530115A (ja) * 2009-06-19 2012-11-29 レツク・フアーマシユーテイカルズ・デー・デー 置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA034601B1 (ru) * 2007-08-06 2020-02-25 Милленниум Фармасьютикалз, Инк. Способ получения бороновых кислот
EA030685B1 (ru) * 2008-06-17 2018-09-28 Милленниум Фармасьютикалз, Инк. Способ получения соединения боронатного эфира

Also Published As

Publication number Publication date
NZ550522A (en) 2010-08-27
JP2013100378A (ja) 2013-05-23
DK3385267T3 (da) 2021-11-01
US20050240047A1 (en) 2005-10-27
RS65253B1 (sr) 2024-03-29
UA90108C2 (ru) 2010-04-12
EA012927B1 (ru) 2010-02-26
IL219856A0 (en) 2012-06-28
AU2005230930A1 (en) 2005-10-20
CN103396427B (zh) 2018-04-13
TWI386212B (zh) 2013-02-21
NO343966B1 (no) 2019-07-29
NO338905B1 (no) 2016-10-31
UY35578A (es) 2016-01-08
JP6193960B2 (ja) 2017-09-06
PT3385267T (pt) 2021-11-23
CA2738706C (en) 2014-10-14
CA2853272A1 (en) 2005-10-20
SG10201600029PA (en) 2016-02-26
NO20064893L (no) 2006-12-22
NO20171939A1 (no) 2006-12-22
RS62738B1 (sr) 2022-01-31
NL1033189A1 (nl) 2007-10-22
ES2457593T3 (es) 2014-04-28
NL1028639A1 (nl) 2005-10-20
SI3385267T1 (sl) 2022-04-29
DK1756121T3 (da) 2012-01-09
US10000529B2 (en) 2018-06-19
MY145427A (en) 2012-02-15
CY1124753T1 (el) 2022-07-22
PE20110075A1 (es) 2011-02-17
ZA200608689B (en) 2007-09-26
AR097309A2 (es) 2016-03-02
AR049374A1 (es) 2006-07-26
UY28830A1 (es) 2005-09-30
NL1033190A1 (nl) 2007-04-23
AR097310A2 (es) 2016-03-02
CR8653A (es) 2007-10-23
TW200616646A (en) 2006-06-01
SG10201800972PA (en) 2018-03-28
US7714159B2 (en) 2010-05-11
CN111925385B (zh) 2023-11-21
EP3385267B1 (en) 2021-09-29
CN1960996B (zh) 2016-04-20
HK1257298A1 (zh) 2019-10-18
ES2371652T3 (es) 2012-01-05
IL219856A (en) 2015-05-31
KR20070007873A (ko) 2007-01-16
US20150038706A1 (en) 2015-02-05
MX367324B (es) 2019-08-15
SG182998A1 (en) 2012-08-30
DOP2011000293A (es) 2011-12-15
LT3385267T (lt) 2021-11-10
EP1756121B1 (en) 2011-08-24
IL219853A (en) 2015-05-31
HK1100004A1 (en) 2007-08-31
DK2377869T3 (da) 2014-04-14
CN1960996A (zh) 2007-05-09
IL178250A0 (en) 2006-12-31
DK4008721T3 (da) 2024-03-25
WO2005097809A3 (en) 2006-02-16
US20200369722A1 (en) 2020-11-26
JP5894952B2 (ja) 2016-03-30
CA2560886C (en) 2014-08-12
CA2738706A1 (en) 2005-10-20
JP2010241816A (ja) 2010-10-28
EP2377869A1 (en) 2011-10-19
ECSP066960A (es) 2006-12-20
CL2010000350A1 (es) 2011-01-28
HRP20212002T1 (hr) 2022-04-01
EP4008721A1 (en) 2022-06-08
US20190330270A1 (en) 2019-10-31
HRP20140339T1 (hr) 2014-05-09
PL2377869T3 (pl) 2014-07-31
US20200157143A1 (en) 2020-05-21
JP4558039B2 (ja) 2010-10-06
SI1756121T1 (sl) 2012-03-30
NO344610B1 (no) 2020-02-10
NO20161350A1 (no) 2006-12-22
CY1112053T1 (el) 2015-11-04
US20210395301A1 (en) 2021-12-23
PL4008721T3 (pl) 2024-05-13
EP4008721B1 (en) 2024-01-03
CL2014002252A1 (es) 2014-12-05
PL1756121T3 (pl) 2012-02-29
EP2377868A1 (en) 2011-10-19
PL3385267T3 (pl) 2022-02-14
CN108329337A (zh) 2018-07-27
NL1033190C2 (nl) 2007-11-27
PT1756121E (pt) 2011-11-30
KR100939598B1 (ko) 2010-02-01
PE20060162A1 (es) 2006-04-07
ATE521612T1 (de) 2011-09-15
CN111925385A (zh) 2020-11-13
NL1033189C2 (nl) 2008-08-14
RS53259B (en) 2014-08-29
US20100174072A1 (en) 2010-07-08
HRP20110846T1 (hr) 2011-12-31
HK1246300A1 (zh) 2018-09-07
EP1756121A2 (en) 2007-02-28
AU2005230930B2 (en) 2011-09-29
HUE056859T2 (hu) 2022-03-28
EP3385267A1 (en) 2018-10-10
US9862745B2 (en) 2018-01-09
WO2005097809A2 (en) 2005-10-20
SG151322A1 (en) 2009-04-30
US20180265546A1 (en) 2018-09-20
ES2899606T3 (es) 2022-03-14
UY34969A (es) 2015-02-27
JP5414625B2 (ja) 2014-02-12
US20190112334A1 (en) 2019-04-18
US20160362449A1 (en) 2016-12-15
NZ586824A (en) 2012-03-30
SG182999A1 (en) 2012-08-30
HRP20240307T3 (hr) 2024-05-10
NZ598172A (en) 2013-08-30
US8283467B2 (en) 2012-10-09
CY1115336T1 (el) 2017-01-04
PE20142402A1 (es) 2015-02-04
ME01975B (me) 2015-05-20
NL1028639C2 (nl) 2007-01-17
RS51983B (en) 2012-02-29
US20130005968A1 (en) 2013-01-03
CN103396427A (zh) 2013-11-20
IL219853A0 (en) 2012-06-28
CA2859119A1 (en) 2005-10-20
JP2007530687A (ja) 2007-11-01
BRPI0509587A (pt) 2007-09-25
PT2377869E (pt) 2014-04-15
PT4008721T (pt) 2024-03-21
NO20191065A1 (no) 2006-12-22
CA2560886A1 (en) 2005-10-20
US20220204558A1 (en) 2022-06-30
CN107474062A (zh) 2017-12-15
FI4008721T3 (fi) 2024-03-19
HK1164320A1 (en) 2012-10-19
US20180044377A1 (en) 2018-02-15
JP2016056180A (ja) 2016-04-21
EP2377869B1 (en) 2014-01-29
SI2377869T1 (sl) 2014-05-30
LT4008721T (lt) 2024-03-25
CN108329337B (zh) 2021-06-25
US20210171574A1 (en) 2021-06-10
IL178250A (en) 2012-06-28

Similar Documents

Publication Publication Date Title
EA200601795A1 (ru) Синтез эфиров бороновой кислоты и кислотных соединений
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
MX2012001463A (es) Proceso para la fabricacion de compuestos.
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
TW200728310A (en) Process for the preparation of ferri-succinylcasein
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
IN2012DN01968A (ru)
UA97241C2 (ru) Способ получения ингибиторов вич-протеазы
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
MX2012003488A (es) Proceso para la elaboracion de n-acil-bifenil-alanina.
TW200612959A (en) Method for preparing hydroxamic acids
EA200870038A1 (ru) Способ получения аминов
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
TW200806304A (en) Maitake mushroom extract and composition containing the same for enhance production of sebum
DE602007007358D1 (de) Verfahren zur synthese von 2,5-dihydroxyterephthalsäure
EA200800466A1 (ru) Способ получения эрбумина периндоприла
TW200720287A (en) Improved process for the extraction of betulinic acid
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
SE0402199D0 (sv) New process I
CY1106649T1 (el) Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων
EA200970203A1 (ru) Новый способ получения эфира 3-амино-5-фтор-4-диалкоксипентановой кислоты
MX2009003196A (es) Proceso para la preparacion de y-butirolactonas.
UA29068U (ru) Способ изготовления конструкционной смеси "ПЕНОРЕЗОЛ"